Ending clinical trials with no warning can put patients at risk.

In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the evolution of women's inclusion in ...

Over the past few months, investigative journalist Charles Piller has published—eg, in The Daily Mail, The New York Times, ...

Clinical symptoms and signs are a bridge between biomedicine and traditional medicine [TM]. These can be associated with diseases incl. their diagnosis, pharmacological targets, and the use of ...

In the corridors of NHS hospitals, I've watched healthcare professionals scramble between patients, their attention stretched ...

The landscape of clinical trials has undergone significant changes, as highlighted in the current Series of six papers published in The Lancet Global Health. The WHO guidance provides a comprehensive ...

Rates of colorectal cancer are increasing by about 2% per year in people under the age of 50. Mortality rates for those ...

A new study has found faster accumulation of tau -- a key indicator of Alzheimer's disease -- in the brains of women over the age of 70 who took menopausal hormone therapy (HT) more than a decade ...

People with autism are typically diagnosed by clinical observation and assessment. To deconstruct the clinical decision process, which is often subjective and difficult to describe, researchers used a ...

In an “emotion-packed” meeting, the Spokane City Council approved a controversial proposal to sell at least 500 stray dogs ...

With the first licenses for providing psychedelic mushrooms issued in Colorado, excitement and questions build around the fungi’s potential, affordability and safety.

It was a moment that would change the landscape of medical education forever. The room buzzed with anticipation as two ...